The board has considered and accepted the Resignation of Mrs . Dakshita Jain as Non Executive Independent Director of the company w.e.f. November 24, 2025.
Announcement under Regulation 30 (LODR)-Resignation of Director
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Nov 24 2025
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Nov 14 2025
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Nov 12 2025
- Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025.
Later from Venmax Drugs & Pharmaceuticals
- Closure of Trading Window
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Dec 26 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jan 12 2026
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Feb 09 2026
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals